Product Categories
| Country: | United States |
|---|---|
| Tel: | 781-+1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | info@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| α-Amylase | NULL | 9000-90-2 | Details |
| D-phenylalanine analogue；(R)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid | C10H11NO2 | 103733-65-9 | Details |
| (R)-3-Hydroxyisobutyric acid | C4H8O3 | 1910-47-0 | Details |
| 3-Hydroxyisobutyric acid；(S)-3-Hydroxyisobutyric acid | C4H8O3 | 2068-83-9 | Details |
| ASP3026；ASP 3026 | C29H40N8O3S | 1097917-15-1 | Details |
| (R)-(-)-JQ1 Enantiomer | C23H25ClN4O2S | 1268524-71-5 | Details |
| (S)-Metolachor | C15H22ClNO2 | 87392-12-9 | Details |
| α-Muricholic acid | C24H40O5 | 2393-58-0 | Details |
| Bikinin；Abrasin | C9H9BrN2O3 | 188011-69-0 | Details |
| Tubastatin A；Tubastatin A BASE | C20H21N3O2 | 1252003-15-8 | Details |
| (S)-Dolaphenine hydrochloride | C11H13ClN2S | 135383-60-7 | Details |
| LHW090-A7 | C20H22ClNO4 | 1308256-94-1 | Details |
| Capmatinib；INCB28060;NVP-INC280;INC-280 | C23H17FN6O | 1029712-80-8 | Details |
| Fasoracetam | C10H16N2O2 | 110958-19-5 | Details |
| 3-AP；OCX191;PAN-811;NSC663249;Triapine | C7H9N5S | 143621-35-6 | Details |
| PH-797804；PH797804 | C22H19BrF2N2O3 | 586379-66-0 | Details |
| DBEQ；JRF 12 | C22H20N4 | 177355-84-9 | Details |
| RN486 | C35H35FN6O3 | 1242156-23-5 | Details |
| Cinaciguat；BAY 58-2667 | C36H39NO5 | 329773-35-5 | Details |
| PFI-4；PFI4;PFI 4 | C21H24N4O3 | 900305-37-5 | Details |
| HA14-1 | C17H17BrN2O5 | 65673-63-4 | Details |
| WHI-P154；Jak3 inhibitor ii | C16H14BrN3O3 | 211555-04-3 | Details |
| GSK-5959；GSK 5959 | C22H26N4O3 | 901245-65-6 | Details |
| Gedatolisib；PKI-587;PF-05212384 | C32H41N9O4 | 1197160-78-3 | Details |
| WAY-262611；WAY262611;WAY 262611 | C20H22N4 | 1123231-07-1 | Details |
| CAY10603；BML-281;HDAC6 Inhibitor | C22H30N4O6 | 1045792-66-2 | Details |
| Infigratinib；BGJ-398;NVP-BGJ398 | C26H31Cl2N7O3 | 872511-34-7 | Details |
| GW627368；GW 627368X | C30H28N2O6S | 439288-66-1 | Details |
| AVN-944；VX-944;AVN944 | C25H27N5O5 | 297730-17-7 | Details |
| Dorsomorphin；BML-275;Compound C | C24H25N5O | 866405-64-3 | Details |
| (S)-P7C3-OMe；(R)-P7C3-Ome | C22H20Br2N2O2 | 1235481-43-2 | Details |
| LY294002；LY 294002;SF 1101;NSC 697286 | C19H17NO3 | 154447-36-6 | Details |
| Fedratinib；TG-101348;SAR 302503 | C27H36N6O3S | 936091-26-8 | Details |
| ISX-9；Isoxazole 9 (ISX-9);Isoxazole 9;Isx 9 | C11H10N2O2S | 832115-62-5 | Details |
| Atopaxar Hydrobromide | C29H39BrFN3O5 | 474550-69-1 | Details |
| Luminespib；AUY922;NVP-AUY922;VER-52296 | C26H31N3O5 | 747412-49-3 | Details |
| PF-4708671；PF 4708671;PF4708671 | C19H21F3N6 | 1255517-76-0 | Details |
| RKI1313；RKI-1313;RKI 1313 | C17H16N4O2S | 1342276-76-9 | Details |
| Fexaramine | C32H36N2O3 | 574013-66-4 | Details |
| JNJ-31020028；JNJ 31020028;JNJ31020028 | C34H36FN5O2 | 1094873-14-9 | Details |
| S0859 | C29H24ClN3O3S | 1019331-10-2 | Details |
| Duvelisib；INK1197;IPI-145 | C22H17ClN6O | 1201438-56-3 | Details |
| CHS-828；GMX1778;CHS 828 | C19H22ClN5O | 200484-11-3 | Details |
| Pictilisib；RG7321;GDC-0941 | C23H27N7O3S2 | 957054-30-7 | Details |
| PF-573228；PF 573228 | C22H20F3N5O3S | 869288-64-2 | Details |
| CCG-1423；CCG 1423;CCG1423 | C18H13ClF6N2O3 | 285986-88-1 | Details |
| AM095 | C27H25N2NaO5 | 1345614-59-6 | Details |
| J-147；J147 | C18H17F3N2O2 | 1146963-51-0 | Details |
| Oclacitinib；PF-03394197 | C15H23N5O2S | 1208319-26-9 | Details |
| Apilimod；STA 5326 | C23H26N6O2 | 541550-19-0 | Details |
| Ponalrestat | C17H12BrFN2O3 | 72702-95-5 | Details |
| Taselisib；RG-7604;GDC-0032 | C24H28N8O2 | 1282512-48-4 | Details |
| PFI-2；PFI2;PFI 2;(R)-PFI-2 | C23H25F4N3O3S | 1627676-59-8 | Details |
| Dubermatinib；TP0903 | C24H30ClN7O2S | 1341200-45-0 | Details |
| Ciproxifan maleate；FUB 359 maleate;FUB 359 | C16H18N2O2.C4H4O4 | 184025-19-2 | Details |
| Mertansine；DM1;Maytansinoid DM1 | C35H48ClN3O10S | 139504-50-0 | Details |
| MLN9708；Ixazomib Citrate | C20H23BCl2N2O9 | 1201902-80-8 | Details |
| Defactinib；PF-04554878;VS-6063 | C20H21F3N8O3S | 1073154-85-4 | Details |
| SB-3CT | C15H14O3S2 | 292605-14-2 | Details |
| Omecamtiv mecarbil；CK-1827452 | C20H24FN5O3 | 873697-71-3 | Details |
| U-104；MST-104;NSC-213841;U104;U 104 | C13H12FN3O3S | 178606-66-1 | Details |
| RQ-00203078；RQ00203078 | C21H13ClF6N2O5S | 1254205-52-1 | Details |
| MC1568 | C17H15FN2O3 | 852475-26-4 | Details |
| WHI-P180；Janex 3 | C16H15N3O3 | 211555-08-7 | Details |
| ISRIB | C22H24Cl2N2O4 | 548470-11-7 | Details |
| TH588 | C13H12Cl2N4 | 1609960-31-7 | Details |
| RG108；N-Phthalyl-L-tryptophan | C19H14N2O4 | 48208-26-0 | Details |
| Tiplaxtinin；PAI-039;Tiplasinin | C24H16F3NO4 | 393105-53-8 | Details |
| GSK-923295；GSK923295 | C32H38ClN5O4 | 1088965-37-0 | Details |
| WS3 | C28H30F3N7O3 | 1421227-52-2 | Details |
| RGW 611 | C9H14N4O3 | 6497-78-5 | Details |
| Nimorazole；Nimorazol;Naxogin;K-1900;Nitrimidazine | C9H14N4O3 | 6506-37-2 | Details |
| OAC2 | C15H12N2O | 6019-39-2 | Details |
| OAC1；BAS 00287861 | C14H11N3O | 300586-90-7 | Details |
| CZC-54252；CZC 54252;CZC54252 | C22H25ClN6O4S | 1191911-27-9 | Details |
| Varespladib；LY315920 | C21H20N2O5 | 172732-68-2 | Details |
| A-803467；A803467;A 803467 | C19H16ClNO4 | 944261-79-4 | Details |
| CYM5442 | C23H27N3O4 | 1094042-01-9 | Details |
| AG1557；AG-1557;AG 1557 | C16H14IN3O2 | 189290-58-2 | Details |
| WHI-P258 | C16H15N3O2 | 21561-09-1 | Details |
| Dihydroethidium；Hydroethidine;PD-MY 003 | C21H21N3 | 104821-25-2 | Details |
| LY-364947；LY 364947;LY364947;HTS466284 | C17H12N4 | 396129-53-6 | Details |
| HDAC-IN-7；HBI-8000;CS055;Chidamide | C22H19FN4O2 | 743420-02-2 | Details |
| Bohemine | C18H24N6O | 189232-42-6 | Details |
| AG-1478；AG1478;AG 1478;Tyrphostin AG-1478;NSC 693255 | C16H14ClN3O2 | 153436-53-4 | Details |
| PF-06447475；PF06447475;PF 06447475 | C17H15N5O | 1527473-33-1 | Details |
| SKLB4771；FLT3-?IN-?1;FLT3-IN-1 | C25H27N7O3S2 | 1370256-78-2 | Details |
| CTX-0294885；CTx0294885 | C22H24ClN7O | 1439934-41-4 | Details |
| JANEX-1；WHI-P131;Jak3 inhibitor I | C16H15N3O3 | 202475-60-3 | Details |
| PD153035；ZM 252868;NSC 669364;AG1517;SU-5271 | C16H14BrN3O2 | 153436-54-5 | Details |
| ADX-47273；ADX 47273;BA 94673139 | C20H17F2N3O2 | 851881-60-2 | Details |
| GS967；GS458967 | C14H7F6N3O | 1262618-39-2 | Details |
| NG 52；NG52;NG-52;Compound 52 | C16H19ClN6O | 212779-48-1 | Details |
| Mutant IDH1-IN-1；IDH1-IN-1 | C30H31FN4O2 | 1355326-21-4 | Details |
| 6-OAU；GTPL5846 | C12H21N3O2 | 83797-69-7 | Details |
| KY02111 | C18H17ClN2O3S | 1118807-13-8 | Details |
| NSC-41589；NSC41589;NSC 41589 | C9H11NOS | 6310-41-4 | Details |
| VEGFR-2-IN-5；UNC0064-12;2,4-Pyrimidinediamine with linker;2, 4-Pyrimidinediamine with linker | C19H24N8 | 1430089-64-7 | Details |
| Altiratinib；DCC-2701 | C26H21F3N4O4 | 1345847-93-9 | Details |
| BML-277；C 3742;BML277;BML 277;Chk2 Inhibitor II | C20H14ClN3O2 | 516480-79-8 | Details |
| Product Total： Product Page： | ||||
| 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 | ||||